FDA approves irinotecan liposome for first-line treatment of metastatic pancreatic adenocarcinoma

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-irinotecan-liposome-first-line-treatment-metastatic-pancreatic-adenocarcinoma